Login / Signup

Fecal and serum granulocyte protein levels in inflammatory bowel disease and irritable bowel syndrome and their relation to disease activity.

Helena EkoffNiclas RydellPer M HellströmRobert Movérare
Published in: Clinical and translational gastroenterology (2024)
Fecal MPO and serum NGAL are promising novel biomarkers, in addition to fecal CP, for differentiating between IBD and IBS. Serum NGAL may also predict disease activity in patients with UC.
Keyphrases